In 2019, the first international joint study focusing on fusion genes of infantile gliomas reported that almost all ROS1 or NTRK fusion genes were found in hemispheric primary tumors, and over 80% of these genes were found in malignant tumors [66]. The gene discussed is ROS1; the disease is glioma.